| A nanobody targeting the F-actin capping protein CapG restrains breast cancer metastasis K Van Impe, J Bethuyne, S Cool, F Impens, D Ruano-Gallego, ... Breast cancer research 15, 1-15, 2013 | 131 | 2013 |
| Engineered bacteria as therapeutic agents C Piñero-Lambea, D Ruano-Gallego, LÁ Fernández Current opinion in biotechnology 35, 94-102, 2015 | 113 | 2015 |
| Selection of single domain antibodies from immune libraries displayed on the surface of E. coli cells with two β-domains of opposite topologies V Salema, E Marín, R Martínez-Arteaga, D Ruano-Gallego, S Fraile, ... PloS one 8 (9), e75126, 2013 | 106 | 2013 |
| Type III secretion system effectors form robust and flexible intracellular virulence networks D Ruano-Gallego, J Sanchez-Garrido, Z Kozik, E Nunez-Berrueco, ... Science 371 (6534), eabc9531, 2021 | 58 | 2021 |
| Host-associated niche metabolism controls enteric infection through fine-tuning the regulation of type 3 secretion JPR Connolly, SL Slater, N O’Boyle, RJ Goldstone, VF Crepin, ... Nature Communications 9 (1), 4187, 2018 | 56 | 2018 |
| The Type III Secretion System of Pathogenic Escherichia coli SL Slater, AM Sågfors, DJ Pollard, D Ruano-Gallego, G Frankel Escherichia coli, a versatile pathogen, 51-72, 2018 | 54 | 2018 |
| Citrobacter rodentium relies on commensals for colonization of the colonic mucosa C Mullineaux-Sanders, JW Collins, D Ruano-Gallego, M Levy, ... Cell reports 21 (12), 3381-3389, 2017 | 53 | 2017 |
| Screening and purification of nanobodies from E. coli culture supernatants using the hemolysin secretion system D Ruano-Gallego, S Fraile, C Gutierrez, LÁ Fernández Microbial Cell Factories 18, 1-13, 2019 | 45 | 2019 |
| Engineering the Controlled Assembly of Filamentous Injectisomes in E. coli K-12 for Protein Translocation into Mammalian Cells D Ruano-Gallego, B Álvarez, LA Fernández ACS synthetic biology 4 (9), 1030-1041, 2015 | 45 | 2015 |
| Mapping cytoskeletal protein function in cells by means of nanobodies I Van Audenhove, K Van Impe, D Ruano‐Gallego, S De Clercq, ... Cytoskeleton 70 (10), 604-622, 2013 | 43 | 2013 |
| Enteropathogenic Escherichia coli stimulates effector-driven rapid caspase-4 activation in human macrophages PJ Goddard, J Sanchez-Garrido, SL Slater, M Kalyan, D Ruano-Gallego, ... Cell Reports 27 (4), 1008-1017. e6, 2019 | 37 | 2019 |
| Faecal neutrophil elastase-antiprotease balance reflects colitis severity R Barry, D Ruano-Gallego, ST Radhakrishnan, S Lovell, L Yu, O Kotik, ... Mucosal Immunology 13 (2), 322-333, 2020 | 36 | 2020 |
| A nanobody targeting the translocated intimin receptor inhibits the attachment of enterohemorrhagic E. coli to human colonic mucosa D Ruano-Gallego, DA Yara, L Di Ianni, G Frankel, S Schüller, ... PLoS pathogens 15 (8), e1008031, 2019 | 27 | 2019 |
| The type III secretion system effector network hypothesis J Sanchez-Garrido, D Ruano-Gallego, JS Choudhary, G Frankel Trends in Microbiology 30 (6), 524-533, 2022 | 26 | 2022 |
| Targeted bacterial conjugation mediated by synthetic cell-to-cell adhesions M Robledo, B Álvarez, A Cuevas, S González, D Ruano-Gallego, ... Nucleic Acids Research 50 (22), 12938-12950, 2022 | 12 | 2022 |
| A multiplex antigen microarray for simultaneous IgG and IgM detection against SARS‐CoV‐2 reveals higher seroprevalence than reported D Ruano‐Gallego, M García‐Villadangos, M Moreno‐Paz, ... Microbial Biotechnology 14 (3), 1228-1236, 2021 | 12 | 2021 |
| Citrobacter rodentium relies on commensals for colonization of the colonic mucosa. Cell Rep 21: 3381–3389 C Mullineaux-Sanders, JW Collins, D Ruano-Gallego, M Levy, ... | 10 | 2017 |
| Identification of Nanobodies Blocking Intimate Adherence of Shiga Toxin-Producing Escherichia coli to Epithelial Cells D Ruano-Gallego, LÁ Fernández Shiga Toxin-Producing E. coli: Methods and Protocols, 253-272, 2021 | 1 | 2021 |
| Immunoanalytical Detection of Conserved Peptides: Refining the Universe of Biomarker Targets in Planetary Exploration P Mustieles-del-Ser, D Ruano-Gallego, V Parro Analytical Chemistry, 2024 | | 2024 |
| Engineering Escherichia coli to Combat Cancer C Piñero-Lambea, D Ruano-Gallego, G Bodelón, B Álvarez, ... Microbial Infections and Cancer Therapy, 253-290, 2019 | | 2019 |
